|
| 34312396 | Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. | NPJ Breast Cancer | 2021 |
| 32040611 | Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study. | Eur J Nucl Med Mol Imaging | 2020 |
| 30793811 | Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients. | Head Neck | 2019 |
| 27528118 | Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control. | Radiother Oncol | 2017 |
| 28854069 | Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study. | J Clin Oncol | 2017 |
| 28771540 | 18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy. | PLoS One | 2017 |
| 28573486 | Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patients. | Support Care Cancer | 2017 |
| 26044403 | Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. | Eur Arch Otorhinolaryngol | 2016 |
| 26712958 | Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. | Oncologist | 2016 |
| 26724641 | A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). | Eur J Cancer | 2016 |
| 25673104 | Helical tomotherapy in head and neck cancer: a European single-center experience. | Oncologist | 2015 |
| 26377574 | Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts. | Radiat Oncol | 2015 |
| 24452673 | An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group. | Cancer | 2014 |
| 25128202 | The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein. | BMC Cancer | 2014 |
| 24765823 | HPV-related oropharyngeal cancers in Flanders (Belgium): a multicenter study. | B-ENT | 2014 |
| 24899223 | Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response. | BMC Res Notes | 2014 |
| 22009853 | Tongue cancers during pregnancy: Case reports and review of literature. | Head Neck | 2013 |
| 23953410 | Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. | Radiother Oncol | 2013 |
| 23723331 | The potential of helical tomotherapy in the treatment of head and neck cancer. | Oncologist | 2013 |
| 23425449 | RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. | Radiat Oncol | 2013 |
| 22973959 | The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors. | Curr Pharm Des | 2013 |
| 22345281 | Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model. | Eur J Cardiothorac Surg | 2012 |
| 20882386 | Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients. | Cancer Chemother Pharmacol | 2011 |
| 22047366 | Reference dosimetry for helical tomotherapy: practical implementation and a multicenter validation. | Med Phys | 2011 |
| 21941030 | Experimental determination of the energy response of alanine pellets in the high dose rate 192Ir spectrum. | Phys Med Biol | 2011 |
| 21415302 | Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience. | Br J Radiol | 2011 |
| 20842129 | Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). | Br J Cancer | 2010 |
| 21302785 | Alanine/EPR dosimetry applied to the verification of a total body irradiation protocol and treatment planning dose calculation using a humanoid phantom. | Med Phys | 2010 |
| 19660134 | A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. | BMC Cancer | 2009 |
| 20044628 | Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck. | Anticancer Res | 2009 |
| 17592772 | Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study. | Breast Cancer Res Treat | 2008 |
| 17823386 | Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. | Ann Oncol | 2007 |
| 17960012 | Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. | N Engl J Med | 2007 |
| 17522243 | Intensity-modulated radiation therapy for head and neck carcinoma. | Oncologist | 2007 |
| 15033673 | Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. | Ann Oncol | 2004 |
| 12443806 | Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial. | Radiother Oncol | 2002 |
| 11520362 | Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. | Int J Gynecol Cancer | 2001 |
| 9683362 | Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. | Radiother Oncol | 1998 |
| 9562706 | Obstructive hydrocephalus as complication of a giant nonfunctioning pituitary adenoma: therapeutical approach. | Acta Clin Belg | 1998 |
| 9548015 | Surgery or radiation: is there really a choice for early prostate cancer. | Crit Rev Oncol Hematol | 1998 |
| 9079148 | Merkel cell carcinoma: the use of surgery and radiotherapy for locoregional control. | Acta Chir Belg | 1997 |
| 9426122 | The effect of carbon fibre inserts on the build-up and attenuation of high energy photon beams. | Radiother Oncol | 1997 |
| 8880723 | Deep cerebral invasion by basal cell carcinoma of the scalp. | Neuroradiology | 1996 |
| 8977565 | Palliative effectiveness of radiation therapy in the treatment of superior vena cava syndrome. | Bull Cancer Radiother | 1996 |
| 8674288 | Metastases seen on SPECT imaging despite a normal planar bone scan. | Clin Nucl Med | 1995 |
| 1414316 | [Preoperative radiotherapy and medial maxillectomy. Treatment concept for carcinomas of the nasal cavity and paranasal sinuses]. | Acta Otorhinolaryngol Belg | 1992 |
| 1660300 | Gastric metastases from lung carcinoma. | Ann Oncol | 1991 |
| 3602427 | The value of treatment portal films in radiotherapy for bronchial carcinoma. | Radiother Oncol | 1987 |